FDA approves Boehringer Ingelheim's Cyltezo for inflammatory ailments
The newly approved formulation will be offered as a pre-filled syringe or pre-filled autoinjector.
Source: yahoo.com
Inflammatory Diseases News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Inflammatory Diseases. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Inflammatory Diseases Today - Breaking & Trending Today
Kynos Therapeutics unveils KMO inhibitor trial results
Kynos Therapeutics Ltd, based in Edinburgh, UK, focuses on developing small molecule kynurenine 3-monooxygenase (KMO) inhibitors for inflammatory disorders.
Source: outsourcing-pharma.com
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation
/PRNewswire/ -- TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region,...
Source: prnewswire.co.uk
Pediatric Clinical Trials Market Aims for Remarkable US$26.47 Billion Milestone by 2032
Future Market Insights projects that the paediatric clinical trials market sales will grow at a 5.3% annual pace between 2022 and 2032. From a projected US$ 15 billion in 2021 to a total valuation of US$ 26.47 billion by 2032, this market is anticipated to increase. The increase of chronic illnesses and genetic prob...
Source: pharmiweb.com
Insider Sell: CEO Santos da Silva Jorge Sells 60,000 Shares of MoonLake Immunotherapeutics
Santos da Silva Jorge, CEO of MoonLake Immunotherapeutics (NASDAQ:MLTX), has sold 60,000 shares of the company on February 20, 2024, according to a recent SEC Filing.
Source: yahoo.com